Postmenopausal women experiencing hot flashes in whom estrogen replacement is
contraindicated have alternatives available to them; however, there is no clearly defined …

Hot flushes affect approximately 75% of postmenopausal women and are one of the most
distressing symptoms that women experience as they enter the menopause. The treatment …

Vasomotor symptoms (VMS), commonly called hot flashes or flushes (HFs) and night
sweats, are the menopausal symptoms for which women seek treatment during menopause …

Background Evidence suggests that a high proportion of perimenopausal and
postmenopausal women experience vasomotor symptoms (hot flushes/night sweats) that …

Although hormone replacement therapy is an effective treatment for menopausal symptoms,
it is contraindicated for some women with an increased risk of cancer. It has previously been …

The menopause transition is experienced by 1.5 million women each year and often
involves troublesome symptoms, including vasomotor symptoms, vaginal dryness …

Objectives Evaluation and management of anxiety and depression during the menopausal
transition are complicated by the overlap between some symptoms of affective disorder with …

More than 80% of women experience psychologic or physical symptoms in the late
reproductive years, with varying degrees of severity and disruption in their lives [1]. Some of …

Background Paroxetine is the first non‐hormone therapy for vasomotor symptoms (VMS)
approved based on the results of two phase 3, randomised, placebo‐controlled trials by the …

Background Interest in non-hormonal therapies for the treatment of menopausal symptoms
has increased since the publication of adverse effects of estrogen replacement therapy …